Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (17)

2021

  1. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

2020

  1. Transcatheter Aortic Valve Replacement for Residual Lesion of the Aortic Valve Following “Healed” Infective Endocarditis

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 17, pp. 1983-1996

2019

  1. Infective Endocarditis following Transcatheter Aortic Valve Replacement: Comparison of Balloon-Versus Self-Expandable Valves

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 11

  2. Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 74, Núm. 5, pp. 631-641

2018

  1. Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: Rationale and design of the RASTAVI randomised multicentre study

    BMJ Open, Vol. 8, Núm. 2

  2. Intracardiac shunts following transcatheter aortic valve implantation: A multicentre study

    EuroIntervention

  3. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

  4. The Learning Curve and Annual Procedure Volume Standards for Optimum Outcomes of Transcatheter Aortic Valve Replacement: Findings From an International Registry

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 17, pp. 1669-1679

  5. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation

    Revista Espanola de Cardiologia, Vol. 71, Núm. 5, pp. 357-364

2017

  1. Institutional experience and outcomes of transcatheter aortic valve replacement: Results from an international multicentre registry

    International Journal of Cardiology, Vol. 245, pp. 222-227

  2. Prosthetic Mitral Surgical Valve in Transcatheter Aortic Valve Replacement Recipients: A Multicenter Analysis

    JACC: Cardiovascular Interventions, Vol. 10, Núm. 19, pp. 1973-1981

  3. Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: The AGTP II trial

    BMJ Open, Vol. 7, Núm. 8

2016

  1. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death

    JAMA - Journal of the American Medical Association, Vol. 316, Núm. 10, pp. 1083-1092

  2. Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential Management

    JACC: Cardiovascular Interventions, Vol. 9, Núm. 15, pp. 1603-1614

2015

  1. Infective endocarditis after transcatheter aortic valve implantation results from a large multicenter registry

    Circulation, Vol. 131, Núm. 18, pp. 1566-1574

2010

  1. Role of the paclitaxel-eluting stent and tirofiban in patients with st-elevation myocardial infarction undergoing postfibrinolysis angioplasty the GRACIA-3 randomized clinical trial

    Circulation: Cardiovascular Interventions, Vol. 3, Núm. 4, pp. 297-307

2004

  1. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomised controlled trial

    Lancet, Vol. 364, Núm. 9439, pp. 1045-1053